These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 18612997

  • 1. ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis.
    Huang J, Lin Y, Li L, Qing D, Teng XM, Zhang YL, Hu X, Hu Y, Yang P, Han ZG.
    Mol Carcinog; 2009 Feb; 48(2):130-40. PubMed ID: 18612997
    [Abstract] [Full Text] [Related]

  • 2. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC.
    Cancer; 2008 Apr 01; 112(7):1489-502. PubMed ID: 18286529
    [Abstract] [Full Text] [Related]

  • 3. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
    Shih YL, Shyu RY, Hsieh CB, Lai HC, Liu KY, Chu TY, Lin YW.
    Cancer; 2006 Aug 01; 107(3):579-90. PubMed ID: 16795071
    [Abstract] [Full Text] [Related]

  • 4. Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma.
    Huang J, Zhang YL, Teng XM, Lin Y, Zheng DL, Yang PY, Han ZG.
    BMC Cancer; 2007 Jul 12; 7():126. PubMed ID: 17626620
    [Abstract] [Full Text] [Related]

  • 5. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A.
    Ann Surg Oncol; 2010 Mar 12; 17(3):923-32. PubMed ID: 19898900
    [Abstract] [Full Text] [Related]

  • 6. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
    Mori T, Nomoto S, Koshikawa K, Fujii T, Sakai M, Nishikawa Y, Inoue S, Takeda S, Kaneko T, Nakao A.
    Liver Int; 2005 Apr 12; 25(2):380-8. PubMed ID: 15780064
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reexpression of ARHI inhibits tumor growth and angiogenesis and impairs the mTOR/VEGF pathway in hepatocellular carcinoma.
    Zhao X, Li J, Zhuo J, Cai L.
    Biochem Biophys Res Commun; 2010 Dec 17; 403(3-4):417-21. PubMed ID: 21093415
    [Abstract] [Full Text] [Related]

  • 10. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
    Wang SP, Zhou HJ, Chen XP, Ren GY, Ruan XX, Zhang Y, Zhang RL, Chen J.
    J Exp Clin Cancer Res; 2007 Mar 17; 26(1):117-24. PubMed ID: 17550140
    [Abstract] [Full Text] [Related]

  • 11. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y.
    Clin Cancer Res; 2008 Nov 15; 14(22):7405-12. PubMed ID: 19010857
    [Abstract] [Full Text] [Related]

  • 12. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY, Hsieh SY, Lu YJ, Wu CS, Chen LC, Lo SJ, Wu CT, Chou MY, Huang TH, Chang YS.
    Genes Chromosomes Cancer; 2009 Dec 15; 48(12):1057-68. PubMed ID: 19760608
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G.
    Gastroenterology; 2008 Dec 15; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.